Noema Pharma Stock

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Sign up today and learn more about Noema Pharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Noema Pharma Stock

Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using their novel therapies. Noema Pharma was founded in 2019 and is based in Basel-Stadt, Switzerland.

Funding History

December 2020$54.0M
March 2023$103M

Management

Co-Founder and CEO

Luigi Costa

CMO & Co-Founder

George Garibaldi

Chief Financial Officer

Michael Gutch

Head of Operations

Sally Nixon

VP Clinical Development, Pediatric Programs

Renata Lazarova

VP Clinical Development, Adult Programs

Amine Tahiri

VP Clinical Operations

Simon Roitt

Board of Director

Darren Carroll

Board of Director

Arthur Franken

Board Member

Rachel Mears

Board Member

Nanna Lüneborg

VP Clinical Development, Behavioral Medicine Programs

Smiljana Milosavljevic

Board of Director

Antoine Papiernik

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo